Lupin gets USFDA approval for Diazepam Injection targeting $77.9 million US market
Pharmaceutical major Lupin Ltd on Friday (July 31) said it has received approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Diazepam Injection USP, 10 mg/2 mL (5 mg/mL), single-dose prefilled syringes. The USFDA approved Lupin’s product as bioequivalent to the reference listed drug (RLD) Valium Injection…
